Awarded
Blinatumomab 38,5 μg in 3.08 ml Fertiglsg. Pulver u. Lösungsm. f.e. Konz. z. Herst. e. Infusionslösung St
- Buyer
- PBMG eG
- Winners
- Amgen GmbH
- Contract value
- no value published
- Bids received
- 1
- Published
- 27 Feb 2026
- Awarded
- 29 Dec 2025
- Contract start
- 1 Jul 2026
- Contract end
- 30 Jun 2027stated
- Region
- Hamburg (DE600)